Targeting Muscle Function in DM1 With Small Molecules to Expand Treatment Options Beyond Gene Therapy

11:30 am - Thursday 28th January 2027

  • Highlighting advances in RNA targeting small molecules to demonstrate the benefit of functional improvements achieved through non-genetic mechanisms
  • Exploring emerging small molecules designed to enhance therapeutic benefit and broaden therapeutic development options

Speakers:

Chief Scientific Officer
Arrakis Therapeutics Inc.